REAL WORLD EVIDENCE NEEDS IN ONCOLOGY:
White Paper based on new trial results from ESMO Congress, 20-24 October 2023, Madrid.
The complexity of colorectal cancer, spanning from localized, slow-growing tumors to aggressive forms, necessitates a diverse approach in both research and clinical management. Recent advancements in understanding its molecular and genetic underpinnings have led to more personalized and effective treatment options. However, the disease’s heterogeneity and the developing resistance to existing therapies accentuate the urgent need for ongoing research and clinical trials to improve patient outcomes.
OXON’s analysis of the studies presented at ESMO 2023 and their potential impact on current clinical guidelines and practices, provides a comprehensive perspective, aiding in identifying the RWE gaps in colorectal cancer management.
To download the white paper please complete the following form: